GleamWall
中文EN

QTEX QTREX Quantum Ltd. Annual reports only

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1837493 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY—
TTM net income YoY-19.6%
TTM EPS YoY25.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin0.7%
Operating margin-4,713.8%
Net margin-4,574.4%
FCF margin-3,447.8%
EBITDA margin-4,661.9%

Returns

ROE-397.9%
ROA-197.2%
ROIC (approx.)—
Asset turnover0.04x

Leverage & solvency

Liabilities / assets56.5%
Debt / equity0.00x
Current ratio1.56x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.75x
Accruals ratio-50.1%
Payout ratio—
Capex / revenue35.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$289,000$0
Cost of revenue$287,000$0
Gross profit$2,000$0
R&D expense$7.50M$6.32M
SG&A expense$5.53M$4.18M
Operating income-$13.62M-$11.27M
Pretax income-$13.22M-$11.05M
Income tax$0$0
Net income-$13.22M-$11.05M
EBITDA-$13.47M-$11.10M
EPS (basic)-0.45-0.60
EPS (diluted)-0.45-0.60
Weighted avg. shares (diluted)29.62M18.52M
Balance sheet
Cash & equivalents$3.16M$5.11M
Short-term investments—$700,000
Inventory$735,000$444,000
Current assets$4.41M$6.81M
PP&E, net$452,000$499,000
Total assets$5.34M$8.07M
Current liabilities$2.82M$3.37M
Total liabilities$3.02M$3.75M
Shareholders' equity$2.32M$4.32M
Shares outstanding35.95M24.25M
Cash flow statement
Operating cash flow-$9.86M-$9.37M
Capital expenditure$103,000$164,000
Free cash flow-$9.96M-$9.54M
Investing cash flow$565,000$1.49M
Financing cash flow$7.33M$7.90M
Depreciation & amortization$150,000$171,000
Stock-based compensation$3.58M$1.89M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.